Comparison

tcY-NH2 TFA(327177-34-4 free base) European Partner

Item no. TMO-TP1925L-100mg
Manufacturer TargetMol
Amount 100 mg
Quantity options 100 mg 10 mg 1 mg 200 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 100.00%
Citations Ma et al (2001) Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist. Br.J.Pharmacol. 134 701 PMID:
Smiles C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)/C=C/C3=CC=CC=C3)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N.O=C(O)C(F)(F)F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias TP1925L,Protease-activated Receptor
Shipping Condition Cool pack
Available
Manufacturer - Targets
Protease-activated Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
853.9
Description
tcY-NH2 TFA is a selective PAR4 antagonist peptide. Inhibits endostatin release and platelet aggregation induced by thrombin.
Pathways
GPCR/G Protein

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close